對(duì)照品 > 標(biāo)準(zhǔn)品 > 美國藥典 >
產(chǎn)品基本信息
產(chǎn)品編號(hào)：R701572
產(chǎn)品名稱：Rufloxacin-d3 Hydrochloride
產(chǎn)品CAS：
規(guī)格含量：10mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
R701572
名稱:
Rufloxacin-d3 Hydrochloride
別名:
9-Fluoro-2,3-dihydro-10-(4-methyl--d3-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic Acid Monohydrochloride; ISF 09334-d3; Monos-d3; Qari-d3; Tebraxin-d3; 9-Fluoro-10-(4-methyl-d3-piperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic Acid Hydrochloride
參考CAS號(hào):
Unlabelled: 106017-08-7
分子式:
C??H??D?ClFN?O?S
分子量:
402.89
類別:
Building Blocks; Isotopic Labeled Analogues;
應(yīng)用:
Rufloxacin-d3 Hydrochloride is the labeled analogue of Rufloxacin Hydrochloride (R701570), which inhibits human organic cation transporter 1 (hoCT1) (SLC22A1) but not hOCT2 (SLC22A2), and hOCT3 (SLC22A3) expressed in human embryonic kidney cell.
參考文獻(xiàn)
Mulgaonkar, A., et. al.: Antimicrob. Agents Ch., 57, 2705 (2013)
?您的位置：
